sam tilkins - Nissha 360

23Apr 2025 by sam tilkins No Comments

The Silent Killer – How ECGs Detect Hidden Heart Attacks

By Anna DwyerNearly half of heart attacks strike silently, causing heart damage without noticeable symptoms. These cases are just limited to the older generation. Even young, healthy individuals are at risk of silent, but deadly cardiovascular risks. 1 in 5 heart attack patients are under 40, and cases such as these are rising. Cardiovascular monitoring is essential for catching cardiovascular problems before they arise.The Silent Threat of Heart AttacksWhat is a silent heart attack? Silent heart attacks have few or no recognizable heart attack symptoms. Common symptoms such as chest pain or shortness of breath may not be experienced or may be misdiagnosed during a silent heart attack, meaning that most people may not even realize they are experiencing is a heart attack. Like any heart attack, silent heart attacks…

27Mar 2025 by sam tilkins

What are Hypoallergenic ECG Electrodes? How to Accommodate Sensitive or Fragile Skin

General Health, Patient Monitoring

What are Hypoallergenic ECG Electrodes?For those patients with fragile or sensitive skin, sticking any device to their skin can cause irritation. While looking for a gentle ECG electrode, there are many buzz words used. Unfortunately in the case of the word ‘hypoallergenic’ the FDA has no regulation on its meaning.While “Allergen-Free” and “Hypoallergenic” are enticing terms that are commonly used in marketing, with no regulation they have no real meaning. So let’s dig in to what each of these buzz words can mean.Allergen-Free ElectrodesNothing can be truly “allergen-free” since even the most elemental or basic ingredients can technically cause an allergic reaction to somebody. The term is commonly used when common allergens (latex, certain dyes/fragrances, or metals) are avoided. When finding an electrode that is the best for sensitive skin,…

20Mar 2025 by sam tilkins

The Shift Toward Nearshoring in Medical Device Manufacturing

Capabilities, Manufacturing Excellence

By Amy JearyGlobal supply chain disruptions and evolving trade policies, including potential new tariffs, are prompting medical device manufacturers to rethink sourcing strategies. As geopolitical uncertainties and regulatory shifts loom, companies are increasingly turning to nearshoring—moving production closer to home—to reduce lead times, improve resilience, and navigate potential cost increases more effectively.Why Medical Device Manufacturers Are Nearshoring1. Strengthening Supply ChainsThe COVID-19 pandemic exposed vulnerabilities in global supply chains, with shipping delays and material shortages disrupting production. Nearshoring shortens supply chains, reduces reliance on global logistics, and enables faster market responses.2. Faster Lead TimesNearshoring significantly reduces shipping times, enabling companies to react quickly to demand fluctuations, regulatory changes, and urgent medical needs—critical for high-demand devices like diagnostic equipment and surgical instruments.3. Cost and Regulatory BenefitsAlthough Far East labor costs are lower,…

10Mar 2025 by sam tilkins

Honoring Women’s Contributions in Manufacturing

Capabilities, Manufacturing Excellence

by Reyna AlburquerqueWomen have long played a vital role in shaping industries, economies, and societies. As we celebrate Women’s History Month, we recognize the incredible women in our Dominican Republic facility, where women comprise an impressive 78% of the total employees. Their expertise, dedication, and resilience drive our success. Their contributions not only strengthen our organization but also reflect the broader impact women have on economic growth and social progress. From excelling in high-precision roles to leading change within the free zone sector, these women are a testament to the power of skill, determination, and opportunity. This month, we highlight their influence, celebrate their achievements, and reaffirm our commitment to supporting their continued growth.Roles and Skills: A Workforce Built on Precision and ExpertiseWomen in our facility play essential roles that require…

06Mar 2025 by sam tilkins

Nissha Medical Technologies Strengthens Buffalo-Boston Ties Through Leadership Development Program

Quality

BUFFALO, NY – March 7, 2025 – Nissha Medical Technologies (NMT), a global medical company headquartered in Buffalo, N.Y., is furthering its commitment to leadership development through the Nissha Academy Americas Leadership Development Program (NAALDP), an innovative program in collaboration with Babson College, recently ranked No. 2 among the best colleges in America by The Wall Street Journal/College Pulse, 2025 Best Colleges in the U.S. report and No. 1 in entrepreneurship by U.S. News & World Report, 2024 (MBA program, 31 consecutive years).As a renowned hub of higher education and innovation, Boston has played a key role in shaping NMT’s executive leadership, with several key leaders—including Sam Heleba, CEO (Babson College), and Jonathon Casey, CIO/CSCO (Boston College)—having strong academic and professional foundations in the city. Now, NMT is investing in…

05Feb 2025 by sam tilkins

Defining Excellence in Cardiac Care: HeartSync’s PMA Journey

Patient Monitoring, Quality

In July 2023, Nissha Medical Technologies (NMT) achieved a significant milestone: Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for its HeartSync line of disposable defibrillation electrodes. This marked the culmination of years of collaborative efforts across teams within NMT and external partners, solidifying the company’s reputation as a leading global manufacturer of disposable medical electrodes.A Foundation of ExcellenceThe journey of HeartSync began with the development of a high-quality defibrillation electrode by the HeartSync company, recognized for its safety, efficacy, and cost-effectiveness. NMT identified the potential of HeartSync’s products early on, leading to its acquisition in May 2019. This integration complemented NMT’s core expertise in disposable, wearable medical technologies and positioned HeartSync as a key brand within the company’s portfolio.Expanding Market PresencePrior to PMA approval, HeartSync products,…

20Dec 2024 by sam tilkins

How NMT Redefines Innovation In Healthcare

Capabilities

By Jeff Radziunas and Amy JearyOur world is constantly in flux, and the medical device industry is no exception. Frequent disruptions to our workflow demand flexibility, agility, and a solution-oriented mindset to stay on track and achieve our corporate goals. Fortunately, we have the power to focus on high-potential areas within our control.A Vision for the FutureNissha Medical Technologies aspires to be the best-in-class provider of services and products for the medical device industry. This industry, valued at a staggering $492 billion USD in 2022, presents immense opportunity amidst its diversity. To capitalize on this potential, NMT has strategically chosen to focus on four key technology categories: Robotics, Visualization, Sensing, and Miniaturization, which we believe will lead the market through 2032.Investing in Our PeopleRecognizing the need for continuous improvement to…

19Nov 2024 by sam tilkins

Breakthrough in Kidney Stone Treatment: Nissha and EndoTheia Unveil FlexStone™ Basket

Capabilities, Press Releases

By Amy JearyWe’re excited to announce a significant milestone in the field of minimally invasive surgery: the successful first-in-human clinical trial of the FlexStone™ Basket by our partner, EndoTheia, Inc.A Breakthrough in Kidney Stone TreatmentThe FlexStone™ Basket is a groundbreaking device that offers unparalleled precision and control in kidney stone removal. This innovative technology empowers surgeons to navigate complex anatomical structures with ease, leading to improved patient outcomes and reduced procedural complexity.A Collaborative EffortNissha Medical Technologies is proud to support EndoTheia in bringing this revolutionary device to market. Our partnership with EndoTheia exemplifies our commitment to fostering innovation and accelerating the development of life-changing medical technologies.The Future of Minimally Invasive SurgeryThis achievement marks a significant step forward in the evolution of minimally invasive surgery. By collaborating with visionary companies like…

06Nov 2024 by sam tilkins

Your Guide to Medical Product Ordering FAQs

FAQ

At Nissha Medical Technologies, we understand that ordering medical products can sometimes feel complicated. We've gathered answers to some of the most frequently asked questions to make your ordering experience smoother, whether you’re looking for information on shipping timelines, substitutes for out-of-stock items, or setting up an account. Here's everything you need to know:1. When Will My Order Ship?Shipping times vary based on product availability:In Stock: If the item is in stock, we aim to ship it the same day or the following business day.Out of Stock: For out-of-stock items, it typically takes around 2-4 weeks to ship.Our website provides up-to-date availability details, so you can check if a product is currently in stock and get an estimated arrival time. 2. What Can I Do if My Product is Out…

04Nov 2024 by sam tilkins

Accelerating Robotic Surgery Innovation Through Early-Stage Partnerships

Capabilities, Events, Surgical Supplies

At DeviceTalks West 2024, NMT brought together a cross functional panel of experts in minimally invasive robotic surgery to discuss how early teamwork between academia, startups, and CDMOs fast-track the cutting-edge innovations that are revolutionizing robotic surgery of today. The Nissha Medical Technologies led panel was moderated by Tom Salemi and featured leaders from several of the leading robotic startups that are molding the current landscape of minimally invasive robotic surgery, including EndoQuest Robotics, EndoTheia, Inc. and Virtuoso Surgical.Panel Details:· Mike Springer, VP of Emerging Technologies at Nissha Medical Technologies· Dr. S. Duke Herrell, CEO of Virtuoso Surgical, CMO of EndoTheia, andCo-Founder of the Vanderbilt Institute in Surgery and Engineering· Scott Webster, COO of EndoTheia· Pejman Seyedi, Director of Advanced Visualization at EndoQuest The discussion highlighted the many challenges…

Author: sam tilkins